Home   >    Proteins   >   Mutant Kinases

MEK1 (K97A), Unactive

Recombinant human full-length mutant MEK1 (K97A) was expressed by E. coli using an N-terminal His tag. This kinase-dead protein is designed for up-stream kinase assay.
Catalog No. M02-16H




Catalog No. Pack Size Price (USD)
M02-16H-20 20 ug $215
M02-16H-50 50 ug $435
M02-16H-BULK BULK Contact Us  


Overview:

MEK1 is a member of the dual specificity protein kinase family that acts as a mitogen-activated protein kinase (MAPK) kinase. MEK1 lies upstream of MAPK/ERK and stimulates the enzymatic activity of MAPK/ERK upon a wide variety of extra- and intracellular signals. As an essential component of MAPK/ERK signal transduction pathway, MEK1 is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development (1). Constitutive activation of MEK1 results in cellular transformation. Thus, MEK1 represents a likely target for pharmacologic intervention in proliferative disease such as cancer (2).


Gene Aliases:

MAP2K1, MKK1, MAPKK1, PRKMK1


Genbank Number:


References:


1. Seger, R. et al: The MAPK signaling cascade. FASEB J. 9: 726-735, 1995.

2. Sebolt-Leopold, J S. et al: Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nature Med. 5: 810-816, 1999.


Purity:

Sample Purity Data. For specific information on a given lot, see related technical data sheet.


Storage, Stability and Shipping:

Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.


Molecular Weight:

~49 kDa



PRODUCT RESOURCES
RESEARCH AREAS

Angiogenesis, Apoptosis/Autophagy, Cancer, Cardiovascular Disease, ERK/MAPK Pathway, Invasion/Metastasis, Neurobiology, Ser/Thr Kinases


RELATED PRODUCTS


  MEK1 (EE), Active, M02-12G

  MEKK1, Active, M09-11G

  COT, Active, M16-11G

  MEK3 (MAP2K3), Unactive, M04-14G


SIGNALCHEM BIOTECH INC.


About

Terms of Service

Privacy Policy

Get the latest resources, updates and offers in your inbox